松龄血脉康联合黛力新治疗脑梗死后抑郁临床观察.docVIP

松龄血脉康联合黛力新治疗脑梗死后抑郁临床观察 　　摘要：目的观察松龄血脉康胶囊联合黛力新治疗脑梗死后抑郁病人的临床疗效。方法选取66例脑梗死后抑郁的病人，随机分为对照组（30例）和治疗组（36例）。两组病人均给予脑梗死常规治疗，对照组服用黛力新片剂，治疗组同时服用黛力新片剂及松龄血脉康胶囊。两组疗程均为30 d。分别于治疗前、治疗后测定病人的汉密尔顿抑郁量表（HAMD）、美国国立卫生研究院卒中量表（NIHSS）、Barthel指数（BI），以HAMD量表对病人的抑郁程度及改善状况进行疗效评定。结果与对照组比较，治疗组治疗30 d后HAMA评分、NIHSS评分明显降低（P＜0.05），BI明显提高（P＜0.05），不良反应发生率差异无统计学意义(P＞0.05)。结论 松龄血脉康胶囊联合黛力新治疗脑梗死后抑郁，临床疗效较单用黛力新更为显著。 　　关键词：脑梗死；抑郁；松龄血脉康胶囊；黛力新 　　中图分类号：R743R289.5文献标识码：Adoi:10.3969/j.issn2014.06.008文章编号2014 　　 　　Clinical Observation on Songling Xuemaikang Capsules and Deanxit in the Treatment of Depression after Cerebral Infarction 　　Xiao Zhanchi,Li Gang,Liu Qiumei,et al//Huanggang Center Hospital(Huanggang438000) 　　Abstract：ObjectiveTo observe the curative effects of Songling Xuemaikang capsules(SXC) and deanxit in the treatment of depression after cerebral infarction.Methods Sixtysix patients with depression after cerebral infarction were randomly divided into two groups:Control group（n=30）treated by deanxit and treatment group （n=36）treated by SXC on the basis of routine treatment.Before treatment and after treatment of one month，the two groups were assigned with Hamilton rating seale for depression(HAMD),National Institutes of Health Scoring Scales (NIHSS) and Barthel Index scale (BI) scores，and then compared the two groups.Results Compared with control group，the HAMD score and NIHSS score of treatment group was significantly lowered（P＜0.05），BI score was significantly improved（P＜0.05），but there was no significant differences between the side effects(P＞0.05).ConclusionAddition of Songling xuemaikang capsules to Deanxit showed better efficacy than Deanxit alone for depression after cerebral infarction． 　　Key words：cerebral infarction；depression；Songling Xuemaikang capsules；deanxit 　　 　　脑梗死后抑郁是急性脑梗死常见的并发症，发病率为40.1％［1］，是指继发于脑梗死后以多种精神症状和躯体症状为主的复杂情感心理障碍疾病［2］,严重影响着病人神经功能的恢复和生活质量的提高,近年来逐渐为人们认识、关注和干预。自2010年1月以来本院采用松龄血脉康胶囊联合黛力新治疗脑梗死后抑郁，取得较好效果，现报道如下。 　　1资料与方法 　　1.1一般资料选择2010年1月―201